Brain-imaging tool and stroke risk test help identify cognitive decline early
UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.
View ArticleResetting addicted brain: Laser light zaps away cocaine addiction
By stimulating one part of the brain with laser light, researchers at the National Institutes of Health (NIH) and the Ernest Gallo Clinic and Research Center at UC San Francisco (UCSF) have shown that...
View ArticleWill cell therapy become a 'third pillar' of medicine?
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco...
View ArticleThird-generation device significantly improves capture of circulating tumor...
A new system for isolating rare circulating tumor cells (CTCs) – living solid tumor cells found at low levels in the bloodstream – shows significant improvement over previously developed devices and...
View ArticleAccused of complicity in Alzheimer's, amyloid proteins may be getting a bad rap
Amyloids—clumps of misfolded proteins found in the brains of people with Alzheimer's disease and other neurodegenerative disorders—are the quintessential bad boys of neurobiology. They're thought to...
View ArticlePhase 1 ALS trial is first to test antisense treatment of neurodegenerative...
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis (ALS) – blocking production of a mutant protein that causes an inherited form of the progressive...
View ArticleScientists identify first potentially effective therapy for human prion disease
Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts,...
View ArticleResearchers say one specific microrna promotes tumor growth and cancer spread
Researchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth...
View ArticleBrain cell signal network genes linked to schizophrenia risk in families
New genetic factors predisposing to schizophrenia have been uncovered in five families with several affected relatives. The psychiatric disorder can disrupt thinking, feeling, and acting, and blur the...
View ArticleDementia costs top those for heart disease or cancer, study finds
The monetary cost of dementia in the United States ranges from $157 billion to $215 billion annually, making the disease more costly to the nation than either heart disease or cancer, according to a...
View ArticleOn-and-off approach to prostate cancer treatment may compromise survival
Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study finds.
View ArticleCombo therapy helps knock out fungal meningitis
(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with...
View ArticleIs a better sleeping pill on the way?
(HealthDay)—A new class of sleep medications appears to help people fall asleep without causing grogginess the next day, researchers say.
View ArticleBaldness linked to increased risk of coronary heart disease
Male pattern baldness is linked to an increased risk of coronary heart disease, but only if it's on the top/crown of the head, rather than at the front, finds an analysis of published evidence in the...
View ArticleGenetic vulnerability of lung cancer to lay foundation for new drug options
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells – a specific genetic weakness that can be exploited for new therapies.
View ArticleResearch effort reveals differences in brain activity for two types of mental...
(Medical Xpress)—Researchers in Australia have uncovered what they describe as differences in brain behavior for people diagnosed with either bipolar disorder (BP) or borderline personality disorder...
View ArticleResearchers reveal that immune system like a turbo-charged hybrid car
(Medical Xpress)—Trinity College Dublin scientists have made a significant breakthrough in understanding the immune system that could lead to new treatments for diseases such as sepsis and Type 2...
View ArticleAlkaptonuria: New hope for treatment of rare genetic disease
(Medical Xpress)—Scientists at the University of Liverpool have found that a drug treatment administered at the earliest signs of a rare genetic disease could prevent the condition from developing in...
View ArticleKey link between obesity and type 2 diabetes discovered
(Medical Xpress)—New research published in the journal Cell Metabolism has identified a key mechanism in the immune system involved in the development of obesity-linked type 2 diabetes. The findings...
View ArticleAvoid impulsive acts by imagining future benefits: Waiting more pleasurable...
(Medical Xpress)—Why is it so hard for some people to resist the least little temptation, while others seem to possess incredible patience, passing up immediate gratification for a greater long-term good?
View Article